Medical Device News Magazine

Roderick MacLeod Appointed Chief Financial Officer of Nevro

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Roderick MacLeod has been appointed Chief Financial Officer of Nevro Corp, effective June 15, 2020, with global responsibility for Finance, IT and Customer Service.  Mr. MacLeod succeeds Andrew Galligan, who is retiring but will remain with the Company during a transition period.

“Roderick MacLeod is a proven leader with a track record of success in finance and operations leadership.  We are pleased that Rod is joining the Nevro executive team at a point in our history where his extensive financial, strategic and industry experience will help us accelerate toward long-term sustainable growth and strong financial performance for our shareholders,” said D. Keith Grossman, Chairman, CEO and President, Nevro.

“I’m very pleased to join Nevro and I view this as an exciting opportunity to continue to build a great company while helping patients who suffer from chronic pain,” said Rod MacLeod.  “I look forward to working closely with Keith and the rest of the Nevro team to execute on the Company’s growth strategy.”

Regarding Andrew Galligan’s retirement Grossman added, “Nevro has benefitted tremendously from Andrew’s leadership over the past decade and he has played a vital role in establishing a solid financial and operational foundation for the Company.  On behalf of the entire organization, I want to thank Andrew for his many accomplishments as CFO.  I also want to thank Andrew personally for being a great resource for me as I came on board, and for remaining with the Company during this transition period.”

“I’d like to thank Keith and the entire Nevro team – it’s truly been an honor to be a part of Nevro for these ten years,” said Andrew Galligan, Chief Financial Officer, Nevro.  “I’m proud of all that we’ve accomplished together and I’m confident that the Company is well positioned for future growth and success.”

Roderick MacLeod joins Nevro with more than 25 years of experience in financial and executive leadership roles in healthcare and technology.  Most recently he served as Vice President of Finance of Stryker Endoscopy, a $1.8 billion division of Stryker Corp that develops and manufactures medical devices used in minimally invasive surgical procedures.  During his 16-year career at Stryker Endoscopy, Mr. MacLeod played a key role in growing the division from $500 million to $1.8 billion in revenue.  Prior to this role, Mr. MacLeod was Controller for Stryker Endoscopy.  Previously, Mr. MacLeod was Vice President of Finance and Administration at Lumenare Networks, a Sunnyvale-based software company.  Earlier in his career, Mr. MacLeod was Financial Manager/Controller at United Airlines and was a Senior Operational and Audit Consultant at Arthur Andersen & Co.  Rod MacLeod graduated from the J.L. Kellogg Graduate School of Management at Northwestern University with a Master of Management degree and received his Bachelor of Arts degree in Economics from Harvard University.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”